ADD ANI AS A TRUSTED SOURCE
googleads
Menu

      
      Bharat Biotech completes clinical development for nasal vaccine

Bharat Biotech completes clinical development for nasal vaccine

Hyderabad (Telangana) [India], August 15 (ANI): Bharat Biotech International on Monday said that BBV154 (intranasal...

      
      BB's COVID-19 nasal vaccine phase III trials completed

BB's COVID-19 nasal vaccine phase III trials completed

Paris [France], June 19 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local...

      
      Phase 2,3 trial data of India's first mRNA COVID vaccine...

Phase 2,3 trial data of India's first mRNA COVID vaccine...

New Delhi [India], March 18 (ANI): Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III...

      
      AstraZeneca booster dose works against Omicron, says Oxford...

AstraZeneca booster dose works against Omicron, says Oxford...

London [UK], December 23 (ANI): The University of Oxford, in collaboration with AstraZeneca, has announced interim...

      
      Glenmark to conduct phase III trials of nasal spray it claims...

Glenmark to conduct phase III trials of nasal spray it claims...

New Delhi [India], July 8 (ANI): Glenmark Pharmaceuticals will be conducting a Phase III trial on a nasal spray,...

      
      DCGI likely to approve phase 3 trial data of Covaxin on Tuesday

DCGI likely to approve phase 3 trial data of Covaxin on Tuesday

New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III...


      
      Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III...

Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III...

New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert...

      
      Bharat Biotech has submitted Covaxin's Phase III trial data...

Bharat Biotech has submitted Covaxin's Phase III trial data...

New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech...


      
      'Covaxin shows overall 78 pc interim efficacy, 100 pc...

'Covaxin shows overall 78 pc interim efficacy, 100 pc...

Hyderabad (Telangana) [India], April 21 (ANI): Covaxin, India's indigenous vaccine against COVID-19 demonstrated...

      
      Covaxin row: Bharat Biotech clarifies allegations over...

Covaxin row: Bharat Biotech clarifies allegations over...

New Delhi [India], January 9 (ANI): After a participant who allegedly died days after volunteering for Covaxin trial...

      
      Unseemly haste risks jeopardising India's good reputation:...

Unseemly haste risks jeopardising India's good reputation:...

New Delhi [India], January 4 (ANI): A day after Union Civil Aviation Minister Hardeep Singh Puri called Shashi...

      
      Two weeks after getting first Covaxin trial shot in Haryana,...

Two weeks after getting first Covaxin trial shot in Haryana,...

New Delhi [India], December 5 (ANI): Haryana Home Minister Anil Vij, who received the first dose of Bharat...

Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.